Važnost procjene kvalitete života u bolesnika s kroničnom opstruktivnom plućnom bolešću

Autor: Sanda Škrinjarić Cincar
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Zdroj: Medicus
Volume 25
Issue 1 Pneumonije
ISSN: 1848-8315
1330-013X
Popis: U kliničkim studijama, kao i u svakodnevnoj kliničkoj praksi, bolesnici s kroničnom opstruktivnom plućnom bolešću (KOPB-om) imaju bitno smanjenu kvalitetu života. Brojne studije pokazale su da je prognoza bolesnika s KOPB-om izravno povezana s kvalitetom njihova života. Egzacerbacije i pridružene bolesti uvelike utječu na pogoršanje kvalitete života bolesnika s KOPB-om. Među simptomima te bolesti za smanjenu kvalitetu života najodgovornija je dispneja koju obično imaju teži bolesnici. Međutim, smanjena kvaliteta života prisutna je u bolesnika s KOPB-om svih stupnjeva težine prema GOLD-u, pa i u onih s blagom opstrukcijom dišnih putova. Stoga je osim plućne funkcije uvijek potrebno procjenjivati i bolesnikove simptome. U smjernicama Global Initiative for Chronic Obstructive Lung Disease (GOLD) od 2011. g. pa nadalje simptomi su uključeni u kombiniranu procjenu težine i prognoze bolesti, a poboljšanje zdravstvenog stanja odnosno kvalitete života postalo je jedan od važnih ciljeva liječenja. Kvaliteta života mjeri se upitnicima za procjenu utjecaja bolesti na zdravstveno stanje bolesnika. Upitnici se dijele u dvije osnovne skupine: 1. generičke i 2. upitnike specifične za bolest. U KOPB-u se najčešće upotrebljavaju generički upitnici SF-36 (The Short Form 36 health survey questionnaire) i oni specifični za bolest SGRQ (St. George’s Respiratory Questionnaire). Osim navedenih u kliničkim istraživanjima KOPB-a rabi se velik broj drugih upitnika za procjenu kvalitete života koji nisu primjenjivi u svakodnevnoj kliničkoj praksi. Za procjenu kvalitete života u svakodnevnom radu kliničara osmišljen je jednostavniji upitnik CAT (COPD Assessment Test) koji omogućuje brzu procjenu i praćenje bolesnika te odlično korelira sa znatno složenijim SGRQ-om.
Both clinical studies and daily clinical practice have shown that patients suffering from COPD have a significantly lower quality of life. Numerous studies have demonstrated that the prognosis for COPD patients is directly linked to their quality of life, which is significantly affected by exacerbations and related diseases. In that regard the most obvious symptom is dyspnoea, and usually patients with severe form of the disease suffer from it. However, reduced quality of life is present in all groups of patients categorised using the GOLD guidelines, including those with mild air passages obstruction. It is therefore necessary to assess not only the pulmonary function, but other symptoms as well. The GOLD guidelines from 2011 onward suggest including symptoms in the combination of the assessed severity and risk of the disease. Improving health and life quality in general has become one of the goals of treatment. The quality of life is evaluated using questionnaires to assess the impact of the disease on patient’s general condition. Questionnaires are divided into generic and disease-specific ones. For COPB generic SF-36 questionnaires (The Short-Form 36-item health survey questionnaire) are usually used, as well as the disease-specific one SGRQ (St. George’s Respiratory Questionnaire). In addition, COPD clinical trials use a number of other questionnaires which cannot be applied in daily clinical practice. For this purpose a simpler CAT questionnaire (COPD Assessment Test) has been created, enabling a fast evaluation and monitoring, and it correlates well with a more complex SGRQ.
Databáze: OpenAIRE
Externí odkaz: